E-cigarettes safer than smoking says long-term study

E-cigarettes safer than smoking says long-term study

February 7th, 2017 by

New research, funded by Cancer Research UK, has found that e-cigarettes are less toxic and safer to use compared to conventional cigarettes. The long-term study found that people who swapped smoking regular cigarettes for e-cigarettes or nicotine replacement therapy (NRT) for at least six months, had much lower levels of toxic and cancer causing substances […]

FDA Extends Compliance Date for Ingredient Submissions

January 10th, 2017 by

On December 28 2016, The FDA issued revised guidance for the “Listing of Ingredients in Tobacco Products”. This guidance is intended to assist manufacturers and importers making tobacco product ingredient submissions to the FDA, as required by the Tobacco Control Act. Revisions to this guidance include minor clarifying and editorial changes to promote consistency throughout […]

FDA Extends Compliance Period for Registration and Product Listing

January 6th, 2017 by

On December 9 2016, the FDA issued revised guidance for the “Registration and Product Listing for Owners and Operators of Domestic Tobacco Product Establishments.” In the initial revised guidance issued in July 2016, U.S. manufacturers of newly regulated products faced a deadline of December 31, 2016 for compliance with the registration and product listing requirements […]

Guidance on CLP (Classification, Labelling and Packaging) for electronic cigarettes

January 4th, 2017 by

The TPD (Tobacco Products Directive) states that products may only be placed on the market if they comply with the Directive and with all other relevant EU legislation. One such piece of legislation is ‘European Regulation (EC) No. 1272/2008 on classification, labelling and packaging of substances and mixtures’, otherwise known as the CLP Regulation, which […]

Dr Paul Marshall joins Nerudia as Regulatory Principal

December 13th, 2016 by

We are delighted to today announce that Dr Paul Marshall has joined our team as Regulatory Principal, to support customers with Medicinal, PMTA and TPD projects. As a former Senior Pharmaceutical Assessor for nicotine and CNS related products at the UK MHRA (Medicines and Healthcare products Regulatory Agency), he brings invaluable experience to the role […]

Sign up for our newsletter